 |
 | Prof. Paul Burn
|
|
|
|
Dr. Burn currently serves as the Broin Chair & Director of The Sanford Project, a multidisciplinary research initiative focused on delivering a cure for type 1 diabetes. He also holds an appointment as Professor of Pediatrics at the Sanford School of Medicine of The University of South Dakota.
Prior to joining Sanford Health, Dr. Burn gained extensive leadership and R&D experience in the Pharmaceutical and Biotech industry, in Academia, and in Not-for-profit organizations. Dr. Burn served in the position of Senior Vice President of Research & Development at the Juvenile Diabetes Research Foundation (JDRF); as Director of Metabolic Disease Research & Development at Bayer Health Care; at Eli Lilly & Company where he performed as the Director of Endocrine Research & Clinical Investigation; as Vice President of Research & Development for the Nutrition division at Monsanto/Pharmacia; and at Hoffman-La Roche as the Global Head for the Metabolic Diseases Therapeutic Area and as Vice President of Biotechnology. Previously, Dr. Burn held positions at various academic institutions, including the University of California, San Diego, CA and the University of Basel, Switzerland. Dr. Burn was trained as a biochemist, cell biologist and molecular biologist and holds a Ph.D. from the Biocenter of the University of Basel, Switzerland.
| |
|
